Ignite Creation Date:
2024-05-06 @ 7:50 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02610712
Status:
UNKNOWN
Last Update Posted:
2016-09-21
First Post:
2015-11-17
Brief Title:
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
Sponsor:
National Institute of Neurology and Neurosurgery Mexico
Organization:
National Institute of Neurology and Neurosurgery Mexico
Study Overview
Official Title:
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
Status:
UNKNOWN
Status Verified Date:
2016-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the efficacy of the use of intravenous low-dose ketamine in the treatment of treatment-resistant depression TRD as well as the changes in Glutamate neurotransmission and inflammatory serum markers
Detailed Description:
The purpose of this study is to determine the efficacy of the use of intravenous low-dose ketamine 05 mgkg in the treatment of treatment-resistant depression TRD as well as the changes in Glutamate neurotransmission measured by Magnetic Resonance Imaging Spectroscopy and inflammatory serum markers IL-6 TNF-alpha
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None